Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05507931 · ClinicalTrials.gov registry record · NA
Broccoli Sprouts for Mild Ulcerative Colitis
A NA study of Ulcerative Colitis and Ulcerative Colitis Chronic Mild, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT05507931: Completed NA study of Ulcerative Colitis and Ulcerative Colitis Chronic Mild, sponsored by University of Michigan.
NCT05507931 is a NA study of Ulcerative Colitis and Ulcerative Colitis Chronic Mild that has completed, run by University of Michigan. The registered enrollment target is 23 participants, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05507931, a NA study of Ulcerative Colitis and Ulcerative Colitis Chronic Mild, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to determine the number of servings of broccoli sprouts sufficient to (1) increase sulforaphane levels in the stool and blood and (2) reduce inflammatory markers in patients with mild ulcerative colitis. This is a pilot feasibility study to prepare for a larger randomized controlled trial.
Primary Outcome
Self report documented in the end of study questionnaire. The questionnaire has 11 questions with the feasibility specifically linked to question 7, "how difficult was it to eat broccoli sprouts?" The answers range from 'not at all' (1) to 'very hard' (5) on a likert like scale.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT 1 Serving of broccoli sprouts
- DIETARY_SUPPLEMENT 3 Servings of broccoli sprouts
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2023-05-23 |
| Est. Completion | 2026-01-09 |
| Phase | NA |
What the finished NCT05507931 record still lists
NCT05507931 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Ulcerative Colitis appearing as the primary indexed condition, and to 2 interventions - of which 1 Serving of broccoli sprouts is the first listed.
NCT05507931 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT05507931 about?
NCT05507931 is a clinical study titled "Broccoli Sprouts for Mild Ulcerative Colitis". The goal of this study is to determine the number of servings of broccoli sprouts sufficient to (1) increase sulforaphane levels in the stool and blood and (2) reduce inflammatory markers in patients with mild ulcerative colitis. This is a pilot feasibility study to prepare for a larger randomized c...
What is the current status of trial NCT05507931?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2023-05-23. Estimated completion is 2026-01-09.
What conditions does trial NCT05507931 study?
This clinical trial studies the following conditions: Ulcerative Colitis, Ulcerative Colitis Chronic Mild.
What interventions are being tested in trial NCT05507931?
The interventions under investigation include: 1 Serving of broccoli sprouts (DIETARY_SUPPLEMENT), 3 Servings of broccoli sprouts (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05507931?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05507931 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ulcerative Colitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05507931's enrollment target sits among peer trials
23 110th of 122 higher than 13 of 122 other Ulcerative Colitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ulcerative Colitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
RECRUITING · NA
-
A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis
RECRUITING · NA
-
Nicotinamide Riboside in Ulcerative Colitis
RECRUITING · NA
-
Fermented Food-Supplemented Diet in Ulcerative Colitis
RECRUITING · NA
-
Impact of Prebiotics in Ulcerative Colitis
RECRUITING · NA
-
Tailored Anti-Inflammatory (A-I) Diet for Americans With Ulcerative Colitis (UC)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI